Medicines Approval Notices




NEW ZEALAND GAZETTE

No. 136


Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Levothyroxine sodium 0.025 mg, 0.1 mg, 0.15 mg Tablets Organon International BV, Oss, The Netherlands Thyrax Duotab

Note: Not substitutable with any L-thyroxine sodium product.

This corrects the entry shown in the New Zealand Gazette notice published on 19 August 1993.

Dated this 16th day of August 1993.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.

GO8087


Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Beclamide 330 mg Tablet Chemische Fabrik Promonta GmbH, Hamburg, Germany Neurocèn

To be prescribed by specialists for conditions refractory to first line therapy.

Dated this 18th day of September 1993.

D. SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.

GO8089


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Malathion 0.25% w/w, permethrin 0.50% w/w, piperonyl butoxide 2% w/w, Ofoxacin 0.3% w/v Topical aerosol spray Societe de Conception et d'Applications Thérapeutiques, Marseille, France Para Plus
Ofloxacin Ophthalmic solution Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland Ocuflux
Piperacillin sodium 2.085 g equivalent 2 g piperacillin/tazobactam sodium 268.3 mg equivalent 250 mg tazobactam Powder for reconstitution for IV or IM injection Lederle Pipecillin Inc., Carolina, Puerto Rico Tazocin
Piperacillin sodium 3.127 g equivalent 3 g piperacillin/tazobactam sodium 402.5 mg equivalent 375 mg tazobactam Powder for reconstitution for IV or IM injection
Piperacillin sodium 4.170 g equivalent 4 g piperacillin/tazobactam sodium 536.6 mg equivalent 500 mg tazobactam Powder for reconstitution for IV or IM injection
Bleomycin sulphate 15,000 IU Powder for reconstitution for IV or IM injection David Bull Laboratories Pty Limited, Mulgrave North, Victoria, Australia Bleomycin Sulphate injection

Dated this 16th day of August 1993.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1993, No 136


NZLII PDF NZ Gazette 1993, No 136





✨ LLM interpretation of page content

🏥 Consent to Distribution of Levothyroxine Sodium Tablets

🏥 Health & Social Welfare
16 August 1993
Medicines, Approval, Levothyroxine Sodium, Thyrax Duotab
  • C. Lovelace, Director-General of Health

🏥 Provisional Consent to Distribution of Beclamide Tablets

🏥 Health & Social Welfare
18 September 1993
Medicines, Provisional Approval, Beclamide, Neurocèn
  • D. Smyth, Acting Director-General of Health

🏥 Consent to Distribution of Multiple New Medicines

🏥 Health & Social Welfare
16 August 1993
Medicines, Approval, Malathion, Ofloxacin, Piperacillin, Bleomycin Sulphate
  • C. Lovelace, Director-General of Health